SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001625101-19-000033
Filing Date
2019-09-11
Accepted
2019-09-10 19:28:14
Documents
14
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q/A plse-20190331x10qa.htm 10-Q/A 58047
2 EX-31.1 plse-20190331xex31_1.htm EX-31.1 31411
3 EX-31.2 plse-20190331xex31_2.htm EX-31.2 28658
4 EX-32.1 plse-20190331xex32_1.htm EX-32.1 20357
  Complete submission text file 0001625101-19-000033.txt   217220

Data Files

Seq Description Document Type Size
5 EX-101.INS plse-20190331.xml EX-101.INS 4506
6 EX-101.SCH plse-20190331.xsd EX-101.SCH 3002
7 EX-101.LAB plse-20190331_lab.xml EX-101.LAB 11472
8 EX-101.PRE plse-20190331_pre.xml EX-101.PRE 7531
Mailing Address 3957 POINT EDEN WAY HAYWARD CA 94545
Business Address 3957 POINT EDEN WAY HAYWARD CA 94545 510-906-4600
Pulse Biosciences, Inc. (Filer) CIK: 0001625101 (see all company filings)

IRS No.: 465696597 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-37744 | Film No.: 191086488
SIC: 3841 Surgical & Medical Instruments & Apparatus
Assistant Director 10